New registry to monitor Sotatercept's impact on lung disease patients
NCT ID NCT06751082
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is an observational registry that will follow about 120 adults with pulmonary hypertension who are being treated with the drug sotatercept at the Mayo Clinic. Researchers will track changes in quality of life, exercise ability, heart function, and side effects like bleeding. The goal is to understand how well the drug works in everyday medical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scoliosis's hidden toll: can we predict lung and heart risks?
- Which breathing setting keeps Kids' lungs healthier during heart surgery?
- Could a simple sleep guide ease insomnia in lung disease?
- A Needle-Free heart check? MRI may replace invasive catheterization
- Can a diabetes drug help the lungs? pioglitazone put to the test for pulmonary hypertension
- Zapping lung nerves could ease heart Failure-Related high blood pressure